BIIB vs EAF · P/E 21, rev $9.89B vs rev $538.8M
Biogen Inc (BIIB) versus GrafTech International Ltd (EAF) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
GrafTech International Ltd (EAF) is a electrical equipment & parts company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported EAF revenue for 2024-12-31 was $538.8M. Net income was -$131.2M. Revenue was down 13.2% from 2023-12-31 to 2024-12-31. EAF currently screens at market cap $245.6M.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. EAF currently screens at market cap $245.6M.
Not investment advice. Open the BIIB and EAF stock pages for the full models.
Not investment advice.